BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Treatment
132 results:

  • 1. A practical nomogram for predicting early death in elderly small cell lung cancer patients: A SEER-based study.
    Chen R; Liu Y; Tou F; Xie J
    Medicine (Baltimore); 2024 Apr; 103(17):e37759. PubMed ID: 38669410
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Noscapine and Apoptosis in Breast and Other cancers.
    Calaf GM; Crispin LA; Quisbert-Valenzuela EO
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542508
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Serum Calretinin and Genetic Variability as a Prognostic and Predictive Factor in Malignant Mesothelioma.
    Zupanc C; Franko A; Štrbac D; Kovač V; Dolžan V; Goričar K
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203360
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A diagnostic model based on
    Zhou S; Tsui P; Lin M; Chen G; Chen W; Cai X
    BMC Med Imaging; 2024 Jan; 24(1):14. PubMed ID: 38191331
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.
    Adamo A; Frusteri C; Pilotto S; Caligola S; Belluomini L; Poffe O; Giacobazzi L; Dusi S; Musiu C; Hu Y; Wang T; Rizzini D; Vella A; Canè S; Sartori G; Insolda J; Sposito M; Incani UC; Carbone C; Piro G; Pettinella F; Qi F; Wang D; Sartoris S; De Sanctis F; Scapini P; Dusi S; Cassatella MA; Bria E; Milella M; Bronte V; Ugel S
    Oncoimmunology; 2023; 12(1):2253644. PubMed ID: 37720688
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integrating Network Pharmacology and Experimental Validation to Explore the Effects and Mechanisms of Qinghao Biejia Decoction and Its Active Compound Artemisinin B Against Non-Small-Cell lung cancer.
    Ye Y; Yang Y; Yan L; Zhou L; Yu S; Du Q; Dong X; Yuan Q; Shan L; Guo L
    Drug Des Devel Ther; 2023; 17():2461-2479. PubMed ID: 37637262
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC: a drug-drug interaction study.
    Ma Y; Chen Q; Zhang Y; Xue J; Liu Q; Zhao Y; Yang Y; Huang Y; Fang W; Hou Z; Li S; Wang J; Zhang L; Zhao H
    Cancer Chemother Pharmacol; 2023 Nov; 92(5):411-418. PubMed ID: 37518060
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Risk profiles and a concise prediction model for lymph node metastasis in patients with lung adenocarcinoma.
    Liang S; Huang YY; Liu X; Wu LL; Hu Y; Ma G
    J Cardiothorac Surg; 2023 Jun; 18(1):195. PubMed ID: 37340322
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. 2,4-Dipropylphloroglucinol inhibits the growth of human lung and colorectal cancer cells through induction of apoptosis.
    Kabir SR; Islam T; Mollah MNH
    Med Oncol; 2023 Mar; 40(5):129. PubMed ID: 36964397
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. GSK3β/ITCH/c-FLIP Axis Counteracts TRAIL-induced Apoptosis in Human lung Adenocarcinoma Cells.
    Zheng X; Huang D; Liu X; Liu QY; Gao X; Liu L
    Protein Pept Lett; 2023; 30(3):242-249. PubMed ID: 36644866
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A contrast-enhanced MRI-based nomogram to identify lung metastasis in soft-tissue sarcoma: A multi-centre study.
    Hu Y; Wang H; Yue Z; Wang X; Wang Y; Luo Y; Jiang W
    Med Phys; 2023 May; 50(5):2961-2970. PubMed ID: 36433749
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular interaction of cryptophycin 52 with Caspase 8 for the management of lung cancer during coronavirus outbreak : A computational study.
    Leena Hussein Bajrai ; Sayed Sartaj Sohrab ; Mohammad Khalid ; Mohammad A Kamal ; Esam Ibraheem Azhar
    Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):31-35. PubMed ID: 36227681
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Anti-migratory effect of curcumin on A-549 lung cancer cells via epigenetic reprogramming of
    Mostofi S; Shanehbandi D; Rahmani SA; Asadi M
    Horm Mol Biol Clin Investig; 2022 Dec; 43(4):455-461. PubMed ID: 35993840
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Analysis of cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment: A Systematic Review and Meta-analyses.
    Lin EP; Hsu CY; Berry L; Bunn P; Shyr Y
    JAMA Netw Open; 2022 Aug; 5(8):e2227211. PubMed ID: 35976648
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database.
    Zhang H; Du X; Dong H; Xu W; Zhou P; Liu S; Qing X; Zhang Y; Yang M; Zhang Y
    BMC Gastroenterol; 2022 Jul; 22(1):348. PubMed ID: 35854221
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Adverse Events Following Limited Resection versus Stereotactic Body Radiation Therapy for Early Stage lung cancer.
    Wang Q; Stone K; Kern JA; Slatore CG; Swanson S; Blackstock W; Khan RS; Smith CB; Veluswamy RR; Chidel M; Wisnivesky JP
    Ann Am Thorac Soc; 2022 Dec; 19(12):2053-2061. PubMed ID: 35816617
    [No Abstract]    [Full Text] [Related]  

  • 17. Preparation of Nereid oligopeptide and investigation of the mechanism underlying the induction of apoptosis in human lung cancer H1299 cells.
    Zhang G; Li H; Liu S; Lu M; Tang L; Sun L
    Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35425994
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression.
    Wang WD; Shang Y; Wang C; Ni J; Wang AM; Li GJ; Su L; Chen SZ
    Acta Pharmacol Sin; 2022 Nov; 43(11):2956-2966. PubMed ID: 35422085
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Development and Validation of a Novel Clinical Prediction Model to Predict the Risk of lung Metastasis from Ewing Sarcoma for Medical Human-Computer Interface.
    Li W; Hong T; Xu C; Wang B; Hu Z; Liu Q; Wang H; Dong S; Kang W; Yin C
    Comput Intell Neurosci; 2022; 2022():1888586. PubMed ID: 35392046
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [The efficacy and prognostic factors of immunotherapy in advanced non-small cell lung cancer patients with different driver gene mutations].
    Ma SX; Ma N; Han J; He Z; Wang L; Wang Q
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(13):922-929. PubMed ID: 35385963
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 7.